Citigroup Inc Arcus Biosciences, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Citigroup Inc holds 65,956 shares of RCUS stock, worth $1.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

65,956

Previous 47,653 38.41%

Holding current value

$1.02 Million

Previous $725,000 39.03%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$13.69 - $18.01 $250,568 - $329,637	18,303 Added 38.41%	65,956 $1.01 Million
Q2 2024 Aug 12, 2024	SELL	$14.59 - $18.48 $3.92 Million - $4.96 Million	-268,474 Reduced 84.93%	47,653 $725,000
Q1 2024 May 10, 2024	BUY	$14.83 - $20.18 $2.8 Million - $3.81 Million	188,896 Added 148.47%	316,127 $5.97 Million
Q4 2023 Feb 09, 2024	SELL	$13.43 - $19.63 $248,428 - $363,115	-18,498 Reduced 12.69%	127,231 $2.43 Million
Q3 2023 Nov 09, 2023	BUY	$17.62 - $23.54 $441,962 - $590,453	25,083 Added 20.79%	145,729 $2.62 Million
Q2 2023 Aug 10, 2023	SELL	$16.97 - $22.03 $3.92 Million - $5.1 Million	-231,290 Reduced 65.72%	120,646 $2.45 Million
Q1 2023 May 11, 2023	BUY	$15.96 - $23.15 $3.6 Million - $5.21 Million	225,255 Added 177.81%	351,936 $6.42 Million
Q4 2022 Feb 09, 2023	SELL	$19.7 - $35.71 $2.13 Million - $3.86 Million	-108,002 Reduced 46.02%	126,681 $2.62 Million
Q3 2022 Nov 10, 2022	BUY	$23.23 - $30.07 $1.31 Million - $1.69 Million	56,183 Added 31.48%	234,683 $6.14 Million
Q2 2022 Aug 10, 2022	BUY	$17.23 - $37.73 $2.51 Million - $5.5 Million	145,896 Added 447.48%	178,500 $4.52 Million
Q1 2022 May 12, 2022	SELL	$28.92 - $41.83 $2.21 Million - $3.19 Million	-76,296 Reduced 70.06%	32,604 $1.03 Million
Q4 2021 Feb 10, 2022	BUY	$31.38 - $48.47 $1.46 Million - $2.25 Million	46,415 Added 74.28%	108,900 $4.41 Million
Q3 2021 Nov 10, 2021	BUY	$26.93 - $37.68 $1.68 Million - $2.35 Million	62,485 New	62,485 $2.18 Million

Others Institutions Holding RCUS

# of Institutions

200

Shares Held

51.5M

Call Options Held

236K

Put Options Held

141K

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.12B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account